Nader Sanai
Clinical trials sponsored by Nader Sanai, explained in plain language.
-
Sound waves and Light-Activated drug tested against aggressive brain tumors
Disease control TerminatedThis early-phase study tested a new approach called sonodynamic therapy for people with recurrent high-grade glioma, a fast-growing brain tumor. Participants received a drug called ALA followed by focused ultrasound to activate it. The goal was to check safety and see if the trea…
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Disease control
Last updated May 17, 2026 03:58 UTC
-
Brain tumor drug penetration study halted early
Knowledge-focused TerminatedThis early-phase trial aimed to see how well the drug infigratinib reaches brain tumors in patients with recurrent high-grade glioma (a type of brain cancer) who were scheduled for surgery. Only 7 of the planned 20 participants were enrolled before the study was terminated. The m…
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Knowledge-focused
Last updated May 17, 2026 04:11 UTC